Patients with bronchial asthma who have undergone COVID-19


DOI: https://dx.doi.org/10.18565/pharmateca.2021.5.76-80

E.Yu. Trushina, E.M. Kostina, E.A. Orlova

Penza Institute for Advanced Medical Education – Branch Campus of the Russian Medical Academy of Continuous Professional Education, Penza, Russia, Penza, Russia
Background. Coronavirus infection 2019 (COVID-19) is common worldwide. The significance of bronchial asthma (BA) for the course of COVID-19 is ambiguous.
Objective. Retrospectively analysis of the course of COVID-19 infection in BA patients.
Methods. The case histories of 1167 patients diagnosed with COVID-19, among them 82 (7.02%) patients suffered from BA, were analyzed.
Results. Among BA patients who underwent COVID-19 infection, there were 11 (13.4%) men and 71 (86.6%) women. Among BA patients, diabetes mellitus was found in 5 (6.09%), arterial hypertension – in 70 (85.4%), coronary artery disease – in 8 (9.75%) patients. 5 BA patients died. There were 7 smoking BA patients.
Conclusion. The analysis showed that the prevalence of BA was 7.02% of the total number of COVID-19 infections. Low mortality was revealed in BA patients infected with COVID-19.

About the Autors


Corresponding author: Elena Yu. Trushina, Cand. Sci. (Med.), Teaching Assistant at the Department of Pulmonology and Phthisiology, Penza Institute for Advanced Medical Education – Branch Campus of the RMACPE, Penza, Russia; trushina.lena@mail.ru
Address: 8A Stasova St., Penza 440060, Russian Federation


Similar Articles


Бионика Медиа